Nevsun İnanç Sign in to save

ORCID 0000-0003-2862-0562 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (10)

2× Division of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey
2× Marmara University School of Medicine
1× Division of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey
1× Division of Rheumatology
1× Marmara University, Rheumatology, Istanbul, Turkey
1× Rheumatology, Marmara University School of Medicine, Istanbul, Turkey
1× Rheumatology
1× Marmara University School of Medecine, Rheumatology, Istanbul, Turkey
1× Marmara University School of Medicine, Rheumatology, Istanbul, Turkey
1× Marmara Üniversity

Papers 7 stored

All · Aachen affiliation only

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)
2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

27

citations
OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)
2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

6

citations
After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries
2022 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

51

citations
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
2022 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

137

citations
POS0093 HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)
2021 Annals of the Rheumatic Diseases conference-abstract Pharmacology, Toxicology and Pharmaceutics Pharmacovigilance and Adverse Drug Reactions Open access

0

citations
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
2020 Annals of the Rheumatic Diseases article Medicine Clinical practice guidelines implementation Open access

20

citations
OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)
2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

31

citations

7 results

Nevsun İnanç ▲ Sign in to save

Departments & institutes in Aachen

Papers 7 stored

Nevsun İnanç Sign in to save